Skip to main content
. Author manuscript; available in PMC: 2023 Mar 16.
Published in final edited form as: Chemistry. 2022 Feb 21;28(16):e202200146. doi: 10.1002/chem.202200146

Figure 3.

Figure 3.

Cell killing assays for breast cancer cell lines a) rhamnose conjugates with BT-474 (HER2 overexpression); b) α-Gal conjugates with BT-474 (HER2 overexpression); c) rhamnose conjugates with T47D (HER2 low expression); d) α-Gal conjugates with T47D (HER2 low expression). All assays were performed in triplicate.